Related Experiment Videos
Mechanisms of drug resistance in AML
Michael Andreeff1, Marina Konopleva
1Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cancer Treatment and Research
|December 17, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes.
American journal of hematology·2022
Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia.
American journal of hematology·2022
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
Mitogen-activated protein kinase signaling and drug-induced liver injury: A molecular connection.
Hepatobiliary & pancreatic diseases international : HBPD INT·2026
Dipeptidyl peptidase-4 inhibitors and risk of multiple sclerosis: A Danish nationwide matched case-control study.
Journal of neuroimmunology·2026
Establishment of a cBSA-mediated miRNA delivery system in Camellia sinensis and functional validation of the Cs-miR163/CsSK1 module in cold stress response.
Plant physiology and biochemistry : PPB·2026
Mirtazapine in Treating Functional Dyspepsia: A Systematic Review and Meta-Analysis.
Gastroenterology research·2026